CompanyGraph
At a glance
- Depends onUpstream position: supplies 5 industries, depends on 1
- ScaleMarket cap is $1.51B, above the global median of $1.15B
- FinancialsAltman Z-Score 2.37: grey zone
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.60%Below 5Y avg (1.29%)
Annual Rate
CNY 0.08Paid annual
Payout Ratio
39.3%Sustainable
Last Ex-Dividend
Jun 1, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.19BCNY1.51B · vs all stocks (USD)
Trailing P/E
49.70xvs Medical Instruments & Supplies peers
Revenue (TTM)
5.20BCNY771.76M · vs all stocks (USD)
Profit Margin
3.99%vs Medical Instruments & Supplies peers
Beta
0.3210xvs all stocks
52-Week Change
-12.09%vs all stocks
Market Capitalization
10.19BCNY1.51B · vs all stocks (USD)
Enterprise Value
6.80BCNY1.01B · vs all stocks (USD)
Trailing P/E
49.70xvs Medical Instruments & Supplies peers
Forward P/E
18.14xvs Medical Instruments & Supplies peers
PEG Ratio
1.32xvs Medical Instruments & Supplies peers
Price to Sales (TTM)
1.97xvs Medical Instruments & Supplies peers
Price to Book (MRQ)
1.28xvs Medical Instruments & Supplies peers
Enterprise to Revenue
1.31xvs Medical Instruments & Supplies peers
Enterprise to EBITDA
17.29xvs Medical Instruments & Supplies peers
Gross Margin
30.58%vs Medical Instruments & Supplies peers
Profit Margin
3.99%vs Medical Instruments & Supplies peers
Operating Margin
5.56%vs Medical Instruments & Supplies peers
Return on Assets (TTM)
1.13%vs Medical Instruments & Supplies peers
Return on Equity (TTM)
2.68%vs Medical Instruments & Supplies peers
Revenue (TTM)
5.20BCNY771.76M · vs all stocks (USD)
Revenue per Share (TTM)
6.76CNYUpdated Aug 19, 2026Quarterly Revenue Growth
-2.50%vs Medical Instruments & Supplies peers
Gross Profit (TTM)
1.45BCNY215.43M · vs all stocks (USD)
EBITDA (TTM)
538.25MCNY79.82M · vs all stocks (USD)
Net Income (TTM)
207.76MCNY30.81M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
36.70%vs Medical Instruments & Supplies peers
Operating Cash Flow (TTM)
715.25MCNY106.07M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
414.45MCNY61.46M · vs all stocks (USD)
Trailing Annual Dividend Rate
0.0800CNYUpdated Aug 19, 2026Trailing Annual Dividend Yield
0.60%vs all stocks
5-Year Average Dividend Yield
1.29%vs all stocks
Payout Ratio
39.27%vs Medical Instruments & Supplies peers
Minority Interest (Equity)
238.45MCNYFY2025 · Dec 31, 2025Revenue
5.23BCNYFY2025 · Dec 31, 2025Cost of Goods Sold
3.70BCNYFY2025 · Dec 31, 2025Gross Profit
1.54BCNYFY2025 · Dec 31, 2025Operating Income
325.21MCNY48.23M · vs all stocks (USD)
Pre-tax Income
264.17MCNYFY2025 · Dec 31, 2025Income Tax Expense
52.28MCNYFY2025 · Dec 31, 2025Net Income
211.89MCNYFY2025 · Dec 31, 2025EBIT
265.83MCNYFY2025 · Dec 31, 2025EBITDA (Income Statement)
538.25MCNYFY2025 · Dec 31, 2025Research & Development
337.66MCNYFY2025 · Dec 31, 2025Selling, General & Administrative
361.04MCNYFY2025 · Dec 31, 2025Other Operating Expenses
45.65MCNYFY2025 · Dec 31, 2025Non-operating Interest Income
37.84MCNYFY2025 · Dec 31, 2025Non-operating Interest Expense
1.66MCNYFY2025 · Dec 31, 2025EPS (Basic)
0.2600CNYFY2025 · Dec 31, 2025EPS (Diluted)
0.2600CNYFY2025 · Dec 31, 2025Basic Shares Outstanding
770.68MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
770.68MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
211.89MCNYFY2025 · Dec 31, 2025Minority Interests (P&L)
-11.51MCNYFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025Operating Cash Flow
220.08MCNYFY2025 · Dec 31, 2025Free Cash Flow
-49.06MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
3.05BCNYFY2025 · Dec 31, 2025Starting Profit (CF Statement)
211.89MCNYFY2025 · Dec 31, 2025Other Non-cash Items
26.86MCNYFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
58.51MCNYFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
-77.18MCNYFY2025 · Dec 31, 2025Capital Expenditures
-269.14MCNYFY2025 · Dec 31, 2025Net Acquisitions
42.02MCNYFY2025 · Dec 31, 2025Purchase of Investments
-2.89BCNYFY2025 · Dec 31, 2025Sale of Investments
2.98BCNYFY2025 · Dec 31, 2025Other Investing Activity
1.31MCNYFY2025 · Dec 31, 2025Net Investing Cash Flow
-133.53MCNYFY2025 · Dec 31, 2025Long-term Debt Issuance
76.70MCNYFY2025 · Dec 31, 2025Long-term Debt Payments
-3.00MCNYFY2025 · Dec 31, 2025Common Dividends Paid
-82.02MCNYFY2025 · Dec 31, 2025Other Financing Charges
-12.81MCNYFY2025 · Dec 31, 2025Net Financing Cash Flow
-21.13MCNYFY2025 · Dec 31, 2025Shares Outstanding
765.83MSharesUpdated Aug 19, 2026Float Shares
364.48MSharesUpdated Aug 19, 2026% Held by Insiders
53.46%vs all stocks
% Held by Institutions
11.90%vs all stocks
Total Cash (MRQ)
3.96BCNY586.82M · vs all stocks (USD)
Total Cash per Share (MRQ)
5.20CNYUpdated Aug 19, 2026Total Debt (MRQ)
112.60MCNY16.70M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.0138xvs Medical Instruments & Supplies peers
Current Ratio (MRQ)
1.98xvs Medical Instruments & Supplies peers
Book Value per Share (MRQ)
10.46CNYUpdated Aug 19, 2026Total Assets
13.51BCNY2.00B · vs all stocks (USD)
Total Current Assets
10.17BCNYFY2025 · Dec 31, 2025Total Liabilities
5.34BCNYFY2025 · Dec 31, 2025Total Non-current Assets
3.34BCNYFY2025 · Dec 31, 2025Total Non-current Liabilities
210.37MCNYFY2025 · Dec 31, 2025Total Current Liabilities
5.13BCNYFY2025 · Dec 31, 2025Cash
3.05BCNYFY2025 · Dec 31, 2025Cash Equivalents
69.10MCNYFY2025 · Dec 31, 2025Cash & Cash Equivalents
3.12BCNYFY2025 · Dec 31, 2025Other Short-term Investments
714.71MCNYFY2025 · Dec 31, 2025Accounts Receivable
1.59BCNYFY2025 · Dec 31, 2025Inventory
3.20BCNYFY2025 · Dec 31, 2025Accounts Payable
1.08BCNYFY2025 · Dec 31, 2025Short-term Debt
15.98MCNYFY2025 · Dec 31, 2025Other Current Liabilities
180.68MCNYFY2025 · Dec 31, 2025Long-term Debt
72.19MCNYFY2025 · Dec 31, 2025Other Non-current Liabilities
6.39MCNYFY2025 · Dec 31, 2025Common Stock (Book)
765.83MCNYFY2025 · Dec 31, 2025Retained Earnings
3.17BCNYFY2025 · Dec 31, 2025Total Shareholders' Equity
8.17BCNY1.21B · vs all stocks (USD)
Treasury Stock
63.94MCNYFY2025 · Dec 31, 202552-Week Low
10.42CNYUpdated Aug 19, 202652-Week High
20.37CNYUpdated Aug 19, 202652-Week Change
-12.09%vs all stocks
Beta
0.3210xvs all stocks
50-Day MA
12.00CNYUpdated Aug 19, 2026200-Day MA
14.47CNYUpdated Aug 19, 2026Avg 10-Day Volume
22.12MSharesUpdated Aug 19, 2026Avg 30-Day Volume
16.08MSharesUpdated Aug 19, 2026Diluted EPS (TTM)
0.2700CNYUpdated Aug 19, 2026Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.37: grey zoneSignificant
Altman Z-Score: 2.37
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.51B, above the global median of $1.15BNotable
Market cap (USD): 1,511,647,290.74Global Median: 1,146,734,693.424
Revenue is $771.76M, above the global median of $520.53MNotable
Revenue (USD): 771,755,515.853Global Median: 520,528,949.311
Levered free cash flow is $61.46M, above the global median of $16.24MNotable
Levered free cash flow (USD): 61,462,970.592Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Precision Tsugami (China) Corporation Limited
Tier 1ProductionThroughput-Bound ConversionFlowRule
Beijing Leike Defense Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Tong Yang Industry Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Huadian Energy Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangdong Baolihua New Energy Stock Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleFlow
Nancal Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
Guangzhou Zhiguang Electric Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionRuleSenseMaking
Lingyun Industrial Corporation
Tier 1ProductionThroughput-Bound ConversionFlowRule
CEAT Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule
TPV Technology Co., Ltd.
Tier 1ProductionThroughput-Bound ConversionFlowRule